Live feed08:14:00·1042dPRReleasevia QuantisnowAmylyx Pharmaceuticals Receives CHMP Negative Opinion on its Conditional Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European UnionByQuantisnow·Wall Street's wire, on your screen.AMLX· Amylyx Pharmaceuticals Inc.Health Care
